Investors who held Futu Holdings Limited stock between May 24, 2023, and May 27, 2026, face an August 25, 2026, deadline to seek lead plaintiff status in a pending securities fraud lawsuit. The litigation targets alleged misrepresentations regarding the company’s regulatory compliance status with Chinese authorities.
Stockholm-based ASSA ABLOY has entered into a definitive agreement to acquire Gunnebo Entrance Control, a specialist in speed gates and security revolving doors. The deal, slated to close in late 2026, aims to bolster the Swedish giant's footprint in mature markets through a portfolio of established pedestrian access technologies.
Shares of Pathward Financial, Inc. tumbled 6.3% following the company's July 22, 2026, announcement that nonperforming loans had tripled analyst expectations. Los Angeles-based law firm Schall, Brown & Schwartz has launched a formal investigation into whether the financial services company misled investors regarding its fiscal health and energy-sector portfolio.
Investors in Albertsons Companies, Inc. are under scrutiny as the law firm Schall, Brown & Schwartz launches an investigation into potential securities law violations. The inquiry follows a sharp decline in share value prompted by the company’s July 23, 2026, financial results, which fell short of analyst expectations.
A 65% single-day collapse in MapLight Therapeutics stock has triggered a formal investigation by Schall, Brown & Schwartz LLP. The firm is currently reviewing whether the company misled investors or suppressed critical information regarding the efficacy of its primary schizophrenia drug candidate during recent clinical trials.
ASSA ABLOY has reached a definitive agreement to acquire Gunnebo Entrance Control, a specialist in speed gates and security revolving doors. The move aims to bolster the Swedish giant's footprint in mature global markets by integrating Gunnebo’s established manufacturing network and specialized pedestrian access expertise into its existing systems division.
From October 9 to November 3, 2026, the Tokyo Metropolitan Theatre and Global Ring Theatre will transform into hubs for the second edition of the Autumn Meteorite festival, showcasing a sprawling international lineup of theatre, dance, and immersive workshops designed to challenge modern perspectives.
Investors who purchased Via Transportation shares following the company’s September 2025 initial public offering face a looming August 10 deadline to join a class action lawsuit. The litigation centers on allegations that the transit firm obscured significant regulatory hurdles in Germany while promoting its expansion strategy to prospective shareholders.
Investors who purchased Erasca, Inc. stock between January 14, 2025, and April 26, 2026, are being urged to join a securities class action lawsuit. The litigation, led by Schall, Brown & Schwartz LLP, targets alleged federal securities law violations stemming from misleading statements regarding the company's clinical data.
A class action lawsuit has been filed against Erasca, Inc., alleging the pharmaceutical company misled shareholders regarding the development of its ERAS-0015 drug candidate. The litigation claims the company’s public assertions failed to disclose significant risks concerning patent protections, potentially violating federal securities laws between early 2025 and April 2026.
Investors who purchased Embecta Corp. stock between November 25, 2025, and May 4, 2026, face an August 17, 2026, deadline to join a class action lawsuit. The litigation alleges the medical device company issued false and misleading financial guidance regarding its pen needle market performance during that period.
By shifting from traditional autoregressive constraints to the LongForcing training method, Alibaba’s Amap has enabled its ABot-World-0 model to maintain physical and visual coherence for a full day of interactive generation on a single consumer-grade GPU, shattering the previous industry standard of one-minute stability.
Investors who held Embecta Corp. stock between November 25, 2025, and May 4, 2026, face an August 17, 2026, deadline to participate in a class action lawsuit. Schall, Brown & Schwartz LLP is seeking lead plaintiffs for the action, which alleges the company misled the market regarding its fiscal guidance.
Shares of Roblox Corporation plummeted nearly 27% on July 31 after the company reported stagnant growth and abruptly suspended its full-year financial guidance. The sharp market reaction prompted the Los Angeles-based law firm Schall, Brown & Schwartz to launch a formal investigation into potential securities law violations by company management.
Shareholders who purchased Wise Group plc stock between May 11 and July 23, 2026, are being sought for a class action lawsuit. The litigation, led by Schall, Brown & Schwartz LLP, targets alleged violations of the Securities Exchange Act regarding the company's disclosure of anti-money laundering risks.
Investors who held First Solar stock between February 26, 2025, and February 24, 2026, are being urged to join a class action lawsuit. The filing alleges that the company misled the market regarding its manufacturing transition from Asia to the United States and its strategy for navigating federal tariff impacts.
Investors holding Via Transportation, Inc. stock since its September 2025 initial public offering have until August 10, 2026, to move for lead plaintiff status. The class action lawsuit, filed by Schall, Brown & Schwartz LLP, alleges the company misled the market regarding financial risks following its public debut.
Under the glow of the Confucian Temple in Jinzhong, Shanxi Province, international diplomats and heritage experts gathered on July 15 to launch the "Unity for Prosperity, Heritage for Eternity" week, a summit focused on merging ancient architectural preservation with cutting-edge digital technologies.
Investors who purchased PicS N.V. shares following the company’s January 30, 2026, initial public offering have until August 4, 2026, to join a pending class action lawsuit. The litigation alleges that the firm misled shareholders regarding the integrity of its underwriting and credit evaluation processes.
Hong Kong Exchanges and Clearing Limited has launched its five-year China Government Bond futures contract, providing the first offshore, exchange-listed instrument for managing interest-rate exposure to the mainland market. The move aims to solidify Hong Kong’s role as a primary hub for global investors navigating Chinese fixed-income assets.
A federal class action lawsuit alleges that GRAIL, Inc. misled shareholders by misrepresenting the outcomes of its NHS-Galleri clinical trial. Investors who purchased the company’s stock between May 13, 2025, and February 19, 2026, are now being urged to review their legal options before the upcoming August 4, 2026, filing deadline.
Investors who purchased Badger Meter, Inc. stock between April 18, 2024, and April 16, 2026, face a critical deadline today as a class action lawsuit moves forward. The DJS Law Group is currently organizing shareholders to address allegations that the company masked its true financial performance through deceptive market statements.
August 3 marks the final opportunity for investors who purchased GeneDx Holdings Corp. securities between April 16, 2025, and May 4, 2026, to move for lead plaintiff status in a pending class action lawsuit. The litigation alleges the company misled the market regarding its financial health and operational performance.
After a decade of steering Swedish Orphan Biovitrum through its expansion into rare disease markets, CEO Guido Oelkers has notified the board of his intent to step down. The executive will maintain his leadership responsibilities through January 2027 to facilitate a handover to his eventual successor.
After a decade at the helm of Swedish Orphan Biovitrum AB, CEO Guido Oelkers has notified the board of his intent to resign. The executive will remain in his position through January 2027, allowing the company to initiate a search for a successor to maintain continuity in its rare disease strategy.
Investors who held Bloom Energy Corporation stock between February 27, 2025, and July 8, 2026, are being urged to join a class action lawsuit. The litigation targets alleged violations of federal securities laws, centering on claims that the company misled the market regarding its reliance on Chinese-sourced scandium.
Investors who held Bloom Energy Corporation stock between February 27, 2025, and July 8, 2026, are being sought for a class action lawsuit. The litigation, led by Schall, Brown & Schwartz LLP, alleges the energy firm misled shareholders regarding its reliance on Chinese-sourced scandium procurement channels.
A federal class action lawsuit alleges Capricor Therapeutics misled shareholders by altering clinical trial statistical protocols for its drug, Deramiocel, without prior FDA authorization. The litigation covers investors who purchased stock between December 17, 2025, and July 26, 2026, as the company faces claims of violating the Securities Exchange Act.
Investors who purchased Capricor Therapeutics stock between December 17, 2025, and July 26, 2026, face a critical deadline of September 28, 2026, to seek lead plaintiff status in a securities fraud lawsuit filed by the law firm Schall, Brown & Schwartz LLP regarding alleged misrepresentations of clinical trial efficacy.
Investors who purchased Wise Group plc shares between May 11 and July 23, 2026, are now caught in a class action lawsuit alleging the company misled the market regarding its anti-money laundering protocols and its vulnerability to risks involving the financing of terrorism.
